The researchers excluded people with a history of pancreatitis from the trials, which tells you something
Individuals who are pregnant, planning on becoming pregnant, breastfeeding, have a history of severe kidney or liver disease, pancreatitis, gallbladder disease, diabetic retinopathy, thyroid C-cell tumors, certain types of cancer, or those who have had severe hypersensitivity to Semaglutide or any of its components may not be suitable for this treatment
Hair loss, or alopecia, has been reported by patients using GLP-1 receptor agonists and dual GIP/GLP-1 receptor agonists
The cultural celebration of GLP-1-driven weight loss can reinforce diet culture thinking and deepen body preoccupation
The systems that matter most for dementia prevention In longevity medicine, the practical question is not whether one therapy is good for the brain. The better question is whether the persons overall biology is moving toward resilience or vulnerability